HIV Alert: Best Practices in ART Following Recent Drug Approvals

Listen to downloadable audio from a series of live Webinars by Eric S. Daar, MD, and Joel E. Gallant, MD, MPH, in which best practices in using newly approved ART options for treating patients with HIV are discussed and audience questions on this subject are addressed.
Format: Audio (.mp3)
File Size: 38.86 MB
Released: May 17, 2016

Listen to downloadable audio from a series of live Webinars by Eric S. Daar, MD, and Joel E. Gallant, MD, MPH, in which best practices in using newly approved ART options for treating patients with HIV are discussed and audience questions on this subject are addressed. (39 minutes)

Eric S. Daar, MD, has disclosed that he has received consulting fees from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, Teva, and ViiV and funds for research support from Bristol-Myers Squibb, Gilead Sciences, Merck, and ViiV.

Joel E. Gallant, MD, MPH, has disclosed that he has received consulting fees from Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, and ViiV and funds for research support from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck, Sangamo, and ViiV.

Acknowledgements

Supported by independent educational grants from
Gilead Sciences
ViiV Healthcare

Related Content

Expert audio analysis by David A. Wohl, MD, of key HIV studies presented at IDWeek 2018 and HIV Glasgow 2018 as reported by Clinical Care Options

David A. Wohl, MD Released: November 12, 2018

Analysis from Glasgow 2018 finds no increased risk of neural tube defects with elvitegravir or bictegravir during pregnancy, reported by Clinical Care Options (CCO).

Released: November 9, 2018

SMARTT: neurologic diagnoses in HIV-exposed, uninfected children exposed to prenatal ARVs, presented at IDWeek 2018, reported by Clinical Care Options

Released: November 8, 2018

Retrospective analysis of NA-ACCORD finds greater weight gain in treatment-naive adults with HIV infection initiating integrase inhibitors (INSTIs) vs PI- or NNRTI-based ART

Released: November 6, 2018

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?